ORGO vs CRON

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

ORGO

53.2
AI Score
VS
CRON Wins

CRON

58.7
AI Score

Investment Advisor Scores

ORGO

53score
Recommendation
HOLD

CRON

59score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ORGO CRON Winner
Forward P/E 12.6743 28.7356 ORGO
PEG Ratio 0 0 Tie
Revenue Growth -56.7% 58.4% CRON
Earnings Growth 555.2% 126.8% ORGO
Tradestie Score 53.2/100 58.7/100 CRON
Profit Margin -18.4% 39.1% CRON
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ORGO 1M: -30.1% · 3M: -61.1% CRON 1M: +0.9% · 3M: +17.1%

Current Technical Phase

ORGO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -23.4%), weak momentum, RSI 24

RSI (14): 24.5 · Price: $0.99

CRON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.8% over 20 days), RSI 56

RSI (14): 56.0 · Price: $3.35

Fundamentals Snapshot

Metric ORGO CRON
Market Cap — —
Forward P/E -3.2 13.1
Trailing P/E — 18.1
Revenue (TTM) — —
Revenue Growth -0.6% 0.6%
Gross Margin 0.7% 0.4%
Operating Margin -1.2% 0.2%
EPS -0.87 0.19
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CRON is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.